Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a multicenter, randomized, double-blind, placebo-controlled study to assess safety, tolerability and pharmacokinetics and to explore efficacy of IV infusion of 10 µg/kg/day and 30 µg/kg/day serelaxin for 48 hours compared to placebo, when added to the standard therapy, in approximately 45 Japanese AHF patients.
Epistemonikos ID: 016d7f661b9ee75983742f246e87bd65dcca2928
First added on: May 11, 2024